The mink as a psychopharmacological model
Bauen, A.; Possanza, G.J.
Archives Internationales de Pharmacodynamie et de Therapie 186(1): 133-136
1970
ISSN/ISBN: 0003-9780 PMID: 5528797 Document Number: 26338
Document emailed within 1 workday
Related Documents
Li, K.C.; Powell, D.C.; Aulerich, R.J.; Walker, R.D.; Render, J.A.; Maes, R.K.; Bursian, S.J. 1999: Effects of formalin on bacterial growth in mink feed, feed consumption and reproductive performance of adult mink, and growth of mink kits Veterinary and Human Toxicology 41(4): 225-232Bloom, M.E.; Race, R.E.; Hadlow, W.J.; Chesebro, B. 1975: Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus Journal of Immunology 115(4): 1034-1037
Neuhäuser, G. 1972: Psychopharmacological therapy in children Hippokrates 43(4): 449-463
Angst, J. 1973: Adipositas due to psychopharmacological agents Deutsche Medizinische Wochenschrift 98(26): 1306-1307
Rode, C.P. 1974: How dangerous are psychopharmacological agents? Zeitschrift für Allgemeinmedizin 50(24): 1041-1048
Bowden, C.L. 1992: Psychopharmacological treatment of panic disorder Bulletin of the Menninger Clinic 56(2 Suppl A): A29-A41
Labhardt, F. 1971: Psychopharmacological drugs in psychosomatic medicine Schweizerische Rundschau für Medizin Praxis 60(22): 725-728
Ryba, D.; Halpern, S. 1971: Evaluation of a new psychopharmacological agent in cardiology Minerva Cardioangiologica 19(3): 172-177
Flemenbaum, A. 1981: The use and abuse of clonidine as a psychopharmacological tool Progress in Clinical and Biological Research 68: 209-215
Val'dman, A.V. 1975: Psychopharmacological aspects of emotional stress Vestnik Akademii Meditsinskikh Nauk SSSR 1975(8): 26-33
Dale, J. 1970: Psychopharmacological agent in anxiety states Nordisk Medicin 83(8): 225-231
Helmchen, H. 1971: Psychopharmacological agents in treatment of psychiatric emergencies La Clinica Terapeutica 56(6): 493-499
Salín-Pascual, R.J.; de la Fuente, J.R. 1985: Advances in the psychopharmacological management of the narcoleptic patient Acta Psiquiatrica y Psicologica de America Latina 31(1): 62-68
Pöldinger, W. 1971: Range and mechanism of action of psychopharmacological drugs Schweizerische Rundschau für Medizin Praxis 60(22): 711-719
Loga, S.; Loga-Zec, S. 2009: Comorbidity in psychiatry: its impact on psychopharmacological treatment Psychiatria Danubina 21(3): 347-349
Bättig, K. 1980: The smoking habit and psychopharmacological effects of nicotine Activitas Nervosa Superior 22(4): 274-288
Kovalenko, L.A.; Sukhodolova, G.N. 2012: The use of reamberini in acute poisonings with psychopharmacological drugs in children Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(6): 21-24
Kasper, S.; Jung, B. 1995: Psychiatrically relevant side effects of non-psychopharmacological pharmacotherapy Der Nervenarzt 66(9): 649-661
Maiera, E. 2012: Psychopharmacological treatment and psychoeducational management in bipolar disease Psychiatria Danubina 24(Suppl 1): S56-S58
Thomsen, P.H.; Sørensen, M.J. 2007: Evidence for psychopharmacological treatment of depression in children and adolescents? Ugeskrift for Laeger 169(14): 1289-1294